• Very Long Chain Acyl-CoA Dehydrogenase Deficiency, Gene Mutation Analysis
  • Copper, Liver Tissue
  • Benign neoplasm, pancreas
  • Breast Cancer Panel
  • Culture, Urine
  • B and T Cell Gene Rearrangement, Blood
  • Protoporphyrin, Free, Blood
  • Portal vein thrombosis
  • Oxazepam, Urine
  • CACNA1A (calcium voltage-gated channel subunit alpha1 A) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Methodology
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.